Moolec Science’s General Counsel Buys 1,909 Shares, Signals Long‑Term Confidence Amid Volatile Market Fluctuations
General Counsel’s 1,909‑share stake shows Moolec Science’s leadership confidence despite a 91% drop, hinting at long‑term faith in its protein tech.
4 minutes to read